Evaluation of Sestrin Levels in Patients With Endometriosis
NCT ID: NCT04886037
Last Updated: 2021-08-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2021-02-01
2021-07-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Serum Ages Levels in Patients With Endometriosis
NCT04886024
Serum Trace Element Levels in Some Gynecological Diseases
NCT07210918
Endometrial Biopsy as Diagnostic Method for Endometriosis and Endometrioma
NCT01022372
Postoperative Results of Incisional Endometriosis
NCT03900507
The Effect of Dydrogesterone on Sexual Function in Women With Endometriosis
NCT04287205
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
women with endometriosis
It consists of women between the ages of 18-45 who have been diagnosed with endometriosis by surgery or ultrasonography.
sestrin
Serum sestrin levels involved in inflammation and energy metabolism are compared between endometriosis and healthy control group.
control
It consists of healty women between the ages of 18-45
sestrin
Serum sestrin levels involved in inflammation and energy metabolism are compared between endometriosis and healthy control group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sestrin
Serum sestrin levels involved in inflammation and energy metabolism are compared between endometriosis and healthy control group.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women without endometriosis
Exclusion Criteria
* women who are only suspected endometriosis
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kanuni Sultan Suleyman Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pınar Yalcin bahat
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pinar Yalcin Bahat
Istanbul, İ̇stanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
endo-sestrin
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.